According to the research leader of a laboratory at the Africa Health Research Institute in South Africa, the Omicron version of the coronavirus can partially circumvent protection from two doses of Pfizer and partner BioNTech’s COVID-19 vaccine. Nonetheless, the study found that blood from patients who had received two doses of the vaccination and had […]
from Daily Times https://ift.tt/3GoNF0T
No comments:
Post a Comment